NWAM LLC’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-16,411
| Closed | -$189K | – | 522 |
|
|
2021
Q1 | $189K | Sell |
16,411
-13,541
| -45% | -$156K | 0.02% | 460 |
|
|
2020
Q4 | $289K | Buy |
29,952
+1,400
| +5% | +$13.5K | 0.03% | 354 |
|
|
2020
Q3 | $257K | Sell |
28,552
-146
| -0.5% | -$1.31K | 0.04% | 200 |
|
|
2020
Q2 | $354K | Buy |
28,698
+1,254
| +5% | +$15.5K | 0.05% | 298 |
|
|
2020
Q1 | $246 | Buy |
27,444
+2,830
| +11% | +$25 | 0.01% | 328 |
|
|
2019
Q4 | $241K | Buy |
24,614
+1,700
| +7% | +$16.6K | 0.04% | 343 |
|
|
2019
Q3 | $158K | Sell |
22,914
-1,700
| -7% | -$11.7K | 0.03% | 370 |
|
|
2019
Q2 | $227K | Sell |
24,614
-2,015
| -8% | -$18.6K | 0.05% | 319 |
|
|
2019
Q1 | $418K | Sell |
26,629
-3,454
| -11% | -$54.2K | 0.09% | 213 |
|
|
2018
Q4 | $464K | Buy |
30,083
+915
| +3% | +$14.1K | 0.12% | 170 |
|
|
2018
Q3 | $628K | Sell |
29,168
-875
| -3% | -$18.8K | 0.14% | 153 |
|
|
2018
Q2 | $731K | Sell |
30,043
-475
| -2% | -$11.6K | 0.17% | 133 |
|
|
2018
Q1 | $522K | Sell |
30,518
-1,662
| -5% | -$28.4K | 0.13% | 171 |
|
|
2017
Q4 | $610K | Buy |
32,180
+8,484
| +36% | +$161K | 0.15% | 143 |
|
|
2017
Q3 | $417K | Buy |
23,696
+7,772
| +49% | +$137K | 0.11% | 187 |
|
|
2017
Q2 | $529K | Sell |
15,924
-156
| -1% | -$5.18K | 0.09% | 150 |
|
|
2017
Q1 | $516K | Buy |
16,080
+5,674
| +55% | +$182K | 0.16% | 146 |
|
|
2016
Q4 | $377K | Buy |
+10,406
| New | +$377K | 0.13% | 170 |
|
|
2014
Q4 | – | Sell |
-4,163
| Closed | -$224K | – | 283 |
|
|
2014
Q3 | $224K | Sell |
4,163
-28
| -0.7% | -$1.51K | 0.08% | 239 |
|
|
2014
Q2 | $220K | Buy |
+4,191
| New | +$220K | 0.07% | 260 |
|